AzTrials
AzTrials

Parkinson DiseaseSI-ROBOTICSNCT05005208

SocIal ROBOTics for Active and Healthy Ageing

A study testing rehabilitation program with the support of the technological platform SI-ROBOTICS in people with Parkinson Disease and Aging, run by Istituto Nazionale di Ricovero e Cura per Anziani at 2 sites in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The study was designed to test the acceptability of the Si-Robotics system in a group of 20 subjects with Parkinson's Disease at an early stage, during a rehabilitation treatment based on Irish dancing. Assessments will be performed at the baseline and at the end of the treatment. Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Parkinson Disease, Aging
What is being tested?
rehabilitation program with the support of the technological platform SI-ROBOTICS
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
2 sitesItaly
Study dates
19 May 2022to 29 Mar 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Capacity to consent;
  • Hoen and Yahr scale: 1-2 stage;
  • Functional Ambulation Category (FAC) ≥ 2;
  • Ranking scale score ≤ 3;
  • Stability of drug treatment for at least 1 month;
  • Geriatric Depression Scale 4-items ≤ 1;
  • Mini Mental State Examination ≥ 24;
  • Maintaining an upright posture ≥ 30''.

Who cannot join

  • History of syncopal episodes, epilepsy and vertigo not controlled pharmacologically;
  • Serious dysfunction of the autonomic system;
  • Severe behavioral syndromes not compensated by drugs;
  • Concurrent neurological and/or cardiac diseases;
  • Recent femur fracture
  • Chronic medium to severe pain affecting standing or walking.

Trial locations and contacts

2 sites in 1 country.

Roberta Bevilacqua contact

00390718004767

r.bevilacqua@inrca.it

Elvira Maranesi contact

00390718004767

e.maranesi@inrca.it

Italy2 sites, 2 recruiting
  • IRCCS INRCA Hospital

    Ancona, 60127

    Anna Rita Bonfigli, MSc, 00390718003719, a.bonfigli@inrca.it

    Not yet recruiting
  • IRCCS INRCA Hospital

    Ancona

    Elvira Maranesi, e.maranesi@inrca.it

    Giovanni Riccardi

    Recruiting

Other trials in Italy

About this study

The study was designed to test the acceptability of the Si-Robotics system in a group of 20 subjects with Parkinson's Disease at an early stage, during a rehabilitation treatment based on Irish dancing. Assessments will be performed at the baseline and at the end of the treatment.

Read the detailed description

The study was designed to test the acceptability of the SI-ROBOTICS system in a group of 20 subjects with Parkinson's Disease at an early stage during a rehabilitation treatment.

The SI-ROBOTICS system is composed of multiple technological components with the aim of facilitating a rehabilitation program based on Irish dance and encouraging the execution of dance steps. The SI-ROBOTICS system consists of:

  • ROBOTIC PLATFORM: a social robot that allows the monitoring of patients during sessions, moving around patients safely and, if necessary, intervening in their support.
  • LET'S DANCE GAME: a component that allows users to enjoy the game sessions (setting up of therapy sessions by the therapist, presentation of tasks to the player and execution by the latter, display of feedback on the sessions).
  • ENVIRONMENTAL AND WEARABLE SENSORS: this allows data to be collected on the patient's main clinical parameters (e.g. heart rate, respiratory rate, etc.). These data allow the therapist to know the patient's state during the execution of tasks and the AI reasoner component to have an additional level of information with which to adapt the planning of steps.
  • AI REASONERS: this is the back-end of the Si-Robotics system, i.e. the "intelligent" component that allows the adaptation of the game sessions, based on the users' game performance and the data collected through the sensors. In this way it will be possible to dynamically customize the session according to the user's needs and abilities.
  • ARTIFICIAL VISION SETTING: a commercial camera called Inter Real Sense (https://www.intel.it/content/www/it/it/architecture-and-technology/realsense-overview.html) will be installed in the experimental setting for the extraction of kinematic parameters, saved anonymously and locally on this computer. Also the robotic platform will be equipped with a RealSense camera and will be able to acquire kinematic parameters. To extract features of interest from the signals, proprietary skeleton tracking software of the Real Sense camera will be used, together with specially developed algorithms for feature extraction.

In addition, kinematic and performance parameters will be collected, which will be used by the physiotherapist to evaluate and plan subsequent sessions, and by the system to delineate the levels of difficulty of the exercise.

Being tested
rehabilitation program with the support of the technological platform SI-ROBOTICS
Keywords
Parkinson disease, Older people, Robot, Technology-integrated intervention, Rehabilitation
Medical subject headings
Parkinson Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • rehabilitation program with the support of the technological platform SI-ROBOTICSOther

    Also called SI-ROBOTICS a technological system facilitating a rehabilitation program

    A 16-treatment session will be conducted, divided into 2 training sessions per week, for 8 weeks. The therapy sessions last 60 minutes; each session will involve 2 patients at time. Cardiac and respiratory activity monitoring is planned during robotic treatments in order to detect the heart rate during physical activity. Individual participants must complete at least 80% of the sessions. Recovery of 2 sessions will be possible.

    Each session involves the following activities:

    • Breathing, relaxation and postural harmonization exercises;
    • Active mobility and stretching exercises;
    • Irish dance with the SI-ROBOTICS system;
    • Relaxation exercises.
Study groups in NCT05005208
Study groupRoleWhat they receive
Rehabilitation GroupExperimentalPD subjects will be going through a rehabilitation program based on an Irish dance with the support of the technological platform SI-ROBOTICS
Receives: Other: rehabilitation program with the support of the technological platform SI-ROBOTICS

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in acceptability of the SI-ROBOTICS system

    Acceptability will be assessed using a 52-item questionnaire based on the unified theory of acceptance and use of technology (UTAUT) model. It's a standardized instrument for measuring the likelihood of success for new technology introductions and helps to understand the drivers of its acceptance.

    The questionnaire has 52 questions distributed in 4 key constructs: 1) performance expectancy, 2) effort expectancy, 3) social influence, and 4) facilitating conditions.

    Each question are based on a Likert-type 5-point scale ranging from 1 = strongly disagree to 5 = strongly agree. Increments are integers between 1 to 5.

    Measured: change from baseline to 4 and 8 weeks after intervention commencement

Secondary outcomes (7)
  1. Change in walking speed

    The walking speed will be evaluated by the Six-Minute Walking Test (6MWT).

    Measured: change from baseline to 4 and 8 weeks after intervention commencement

  2. Change in balance

    The change in balance will be evaluated by the Performance-Oriented Mobility Assessment (POMA) consists of two sub-scales: the balance evaluation scale ("balance scale" or POMA-B) and the gait evaluation scale ("gait scale" or POMA-G). The maximum score is 28 points: in detail, the maximum score of the POMA-B is 16, while for the POMA-G the maximum score is 12.

    Measured: change from baseline to 4 and 8 weeks after intervention commencement

  3. Change in fear of falling

    The change in fear of falling will be evaluated by the Short Falls Efficacy Scale - International (FES-I- Short). The cut offs are divided as follows: a score between 7-8 indicates a low concern, between 9-12 a moderate concern and between 14 and 28, high concern.

    Measured: change from baseline to 4 and 8 weeks after intervention commencement

  4. Change in physical performance

    Change in physical performance will be ascertained using the Short Physical Performance Battery (SPPB). Summary scores range from 0-12 and higher scores denote higher physical performance

    Measured: change from baseline to 4 and 8 weeks after intervention commencement

  5. Change in mobility

    Change in mobility will be evaluated by Timed-Up-and-Go (TUG) Test. A score of ten seconds or less indicates normal mobility; times between 11 and 20 seconds are within normal limits for frail elderly and disabled patients; times over 20 seconds indicate that the person requires external assistance and the need for further examination and intervention. A score above 30 seconds suggests that the person may be prone to falls.

    Measured: change from baseline to 4 and 8 weeks after intervention commencement

  6. Change in goal attainment scale

    Change in goal attainment scale (GAS): definition of an individual goal at start, followed by a 6- point numeric scale indicating to what extent the goal is (score 0 till +2) or is not (-3 indicating detoriation till -1) reached.

    Measured: change from baseline to 4 and 8 weeks after intervention commencement

  7. Change in quality of life

    SF-12 Health Survey (SF-12) is composed of 12 items that produce two measurements related to two different aspects of health: physical health and mental health.

    Measured: change from baseline to 4 and 8 weeks after intervention commencement

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Aug 2021
  2. Study start19 May 2022
  3. Primary completion29 Mar 2024 (estimated)
  4. Study completion29 Mar 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05005208
Sponsor's protocol ID
INRCA_001_2021
Acronym
SI-ROBOTICS
Status last verified
Oct 2023
First submitted
5 Aug 2021
Last updated
23 Oct 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Data will be available to other researchers following a documented request to the INRCA investigators.

Publications

  • Bevilacqua R, Maranesi E, Benadduci M, Cortellessa G, Umbrico A, Fracasso F, Melone G, Margaritini A, La Forgia A, Di Bitonto P, Potenza A, Fiorini L, La Viola C, Cavallo F, Leone A, Caroppo A, Rescio G, Marzorati M, Cesta A, Pelliccioni G, Riccardi GR, Rossi L. Exploring Dance as a Therapeutic Approach for Parkinson Disease Through the Social Robotics for Active and Healthy Ageing (SI-Robotics): Results From a Technical Feasibility Study. JMIR Aging. 2025 Jan 14;8:e62930. doi: 10.2196/62930.

    PubMed 39810317
  • Bevilacqua R, Benadduci M, Bonfigli AR, Riccardi GR, Melone G, La Forgia A, Macchiarulo N, Rossetti L, Marzorati M, Rizzo G, Di Bitonto P, Potenza A, Fiorini L, Cortellessa Loizzo FG, La Viola C, Cavallo F, Leone A, Rescio G, Caroppo A, Manni A, Cesta A, Cortellessa G, Fracasso F, Orlandini A, Umbrico A, Rossi L, Maranesi E. Dancing With Parkinson's Disease: The SI-ROBOTICS Study Protocol. Front Public Health. 2021 Dec 21;9:780098. doi: 10.3389/fpubh.2021.780098. eCollection 2021.

    PubMed 34993171

Questions about this trial

What is this clinical trial studying?

A study testing rehabilitation program with the support of the technological platform SI-ROBOTICS in people with Parkinson Disease and Aging, run by Istituto Nazionale di Ricovero e Cura per Anziani at 2 sites in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 23 Oct 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Roberta Bevilacqua (00390718004767, r.bevilacqua@inrca.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in acceptability of the SI-ROBOTICS system (time frame: change from baseline to 4 and 8 weeks after intervention commencement). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05005208, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Oct 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in